These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26030193)

  • 1. Phenotypes of children with 20q13.3 microdeletion affecting KCNQ2 and CHRNA4.
    Okumura A; Atsushi Ishii ; Shimojima K; Kurahashi H; Yoshitomi S; lmai K; Imamura M; Seki Y; Toshiaki Shimizu T; Hirose S; Yamamoto T
    Epileptic Disord; 2015 Jun; 17(2):165-71. PubMed ID: 26030193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletions involving both KCNQ2 and CHRNA4 present with benign familial neonatal seizures.
    Kurahashi H; Wang JW; Ishii A; Kojima T; Wakai S; Kizawa T; Fujimoto Y; Kikkawa K; Yoshimura K; Inoue T; Yasumoto S; Ogawa A; Kaneko S; Hirose S
    Neurology; 2009 Oct; 73(15):1214-7. PubMed ID: 19822871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The variable phenotypes of KCNQ-related epilepsy.
    Allen NM; Mannion M; Conroy J; Lynch SA; Shahwan A; Lynch B; King MD
    Epilepsia; 2014 Sep; 55(9):e99-105. PubMed ID: 25052858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic testing in benign familial epilepsies of the first year of life: clinical and diagnostic significance.
    Zara F; Specchio N; Striano P; Robbiano A; Gennaro E; Paravidino R; Vanni N; Beccaria F; Capovilla G; Bianchi A; Caffi L; Cardilli V; Darra F; Bernardina BD; Fusco L; Gaggero R; Giordano L; Guerrini R; Incorpora G; Mastrangelo M; Spaccini L; Laverda AM; Vecchi M; Vanadia F; Veggiotti P; Viri M; Occhi G; Budetta M; Taglialatela M; Coviello DA; Vigevano F; Minetti C
    Epilepsia; 2013 Mar; 54(3):425-36. PubMed ID: 23360469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel splicing mutation in KCNQ2 in a multigenerational family with BFNC followed for 25 years.
    de Haan GJ; Pinto D; Carton D; Bader A; Witte J; Peters E; van Erp G; Vandereyken W; Boezeman E; Wapenaar MC; Boon P; Halley D; Koeleman BP; Lindhout D
    Epilepsia; 2006 May; 47(5):851-9. PubMed ID: 16686649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epilepsy due to 20q13.33 subtelomere deletion masquerading as pyridoxine-dependent epilepsy.
    Mefford HC; Cook J; Gospe SM
    Am J Med Genet A; 2012 Dec; 158A(12):3190-5. PubMed ID: 23166088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ring chromosome 20 syndrome without deletions of the subtelomeric and CHRNA4--KCNQ2 genes loci.
    Elghezal H; Hannachi H; Mougou S; Kammoun H; Triki C; Saad A
    Eur J Med Genet; 2007; 50(6):441-5. PubMed ID: 17851150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ring chromosome 20: an epileptic channel disorder?].
    Serrano-Castro PJ; Aguilar-Castillo MJ; Olivares-Romero J; Jiménez-Machado R; Molina-Aparicio MJ
    Rev Neurol; 2001 Feb 1-15; 32(3):237-41. PubMed ID: 11310277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KCNQ2 abnormality in BECTS: benign childhood epilepsy with centrotemporal spikes following benign neonatal seizures resulting from a mutation of KCNQ2.
    Ishii A; Miyajima T; Kurahashi H; Wang JW; Yasumoto S; Kaneko S; Hirose S
    Epilepsy Res; 2012 Nov; 102(1-2):122-5. PubMed ID: 22884718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletions or duplications in KCNQ2 can cause benign familial neonatal seizures.
    Heron SE; Cox K; Grinton BE; Zuberi SM; Kivity S; Afawi Z; Straussberg R; Berkovic SF; Scheffer IE; Mulley JC
    J Med Genet; 2007 Dec; 44(12):791-6. PubMed ID: 17675531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A de novo KCNQ2 mutation detected in non-familial benign neonatal convulsions.
    Ishii A; Fukuma G; Uehara A; Miyajima T; Makita Y; Hamachi A; Yasukochi M; Inoue T; Yasumoto S; Okada M; Kaneko S; Mitsudome A; Hirose S
    Brain Dev; 2009 Jan; 31(1):27-33. PubMed ID: 18640800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additional evidence to support the role of the 20q13.33 region in susceptibility to autism.
    Mosca-Boidron AL; Valduga M; Thauvin-Robinet C; Lagarde N; Marle N; Henry C; Pinoit JM; Huet F; Béri-Deixheimer M; Ragon C; Gueneau L; Payet M; Callier P; Mugneret F; Jonveaux P; Faivre L
    Am J Med Genet A; 2013 Jun; 161A(6):1505-7. PubMed ID: 23613186
    [No Abstract]   [Full Text] [Related]  

  • 13. A genotype-first approach for the molecular and clinical characterization of uncommon de novo microdeletion of 20q13.33.
    Traylor RN; Bruno DL; Burgess T; Wildin R; Spencer A; Ganesamoorthy D; Amor DJ; Hunter M; Caplan M; Rosenfeld JA; Theisen A; Torchia BS; Shaffer LG; Ballif BC; Slater HR
    PLoS One; 2010 Aug; 5(8):e12462. PubMed ID: 20805988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KCNQ2 encephalopathy: emerging phenotype of a neonatal epileptic encephalopathy.
    Weckhuysen S; Mandelstam S; Suls A; Audenaert D; Deconinck T; Claes LR; Deprez L; Smets K; Hristova D; Yordanova I; Jordanova A; Ceulemans B; Jansen A; Hasaerts D; Roelens F; Lagae L; Yendle S; Stanley T; Heron SE; Mulley JC; Berkovic SF; Scheffer IE; de Jonghe P
    Ann Neurol; 2012 Jan; 71(1):15-25. PubMed ID: 22275249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similar early characteristics but variable neurological outcome of patients with a de novo mutation of KCNQ2.
    Milh M; Boutry-Kryza N; Sutera-Sardo J; Mignot C; Auvin S; Lacoste C; Villeneuve N; Roubertie A; Heron B; Carneiro M; Kaminska A; Altuzarra C; Blanchard G; Ville D; Barthez MA; Heron D; Gras D; Afenjar A; Dorison N; Doummar D; Billette de Villemeur T; An I; Jacquette A; Charles P; Perrier J; Isidor B; Vercueil L; Chabrol B; Badens C; Lesca G; Villard L
    Orphanet J Rare Dis; 2013 May; 8():80. PubMed ID: 23692823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A KCNQ2 E515D mutation associated with benign familial neonatal seizures and continuous spike and waves during slow-wave sleep syndrome in Taiwan.
    Lee IC; Yang JJ; Li SY
    J Formos Med Assoc; 2017 Sep; 116(9):711-719. PubMed ID: 28038823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete loss of the cytoplasmic carboxyl terminus of the KCNQ2 potassium channel: a novel mutation in a large Czech pedigree with benign neonatal convulsions or other epileptic phenotypes.
    Pereira S; Roll P; Krizova J; Genton P; Brazdil M; Kuba R; Cau P; Rektor I; Szepetowski P
    Epilepsia; 2004 Apr; 45(4):384-90. PubMed ID: 15030501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electroconvulsive seizure thresholds and kindling acquisition rates are altered in mouse models of human KCNQ2 and KCNQ3 mutations for benign familial neonatal convulsions.
    Otto JF; Singh NA; Dahle EJ; Leppert MF; Pappas CM; Pruess TH; Wilcox KS; White HS
    Epilepsia; 2009 Jul; 50(7):1752-9. PubMed ID: 19453707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal seizures associated with a severe neonatal myoclonus like dyskinesia due to a familial KCNQ2 gene mutation.
    Blumkin L; Suls A; Deconinck T; De Jonghe P; Linder I; Kivity S; Dabby R; Leshinsky-Silver E; Lev D; Lerman-Sagie T
    Eur J Paediatr Neurol; 2012 Jul; 16(4):356-60. PubMed ID: 22169383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benign familial neonatal convulsions: always benign?
    Steinlein OK; Conrad C; Weidner B
    Epilepsy Res; 2007 Mar; 73(3):245-9. PubMed ID: 17129708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.